A comparative assessment of CD4 recovery in a cohort of patients on different HAART regimens in a Nigerian tertiary healthcare facility
P Onah, C Idoko, A Kai'gama, S Abdulateef - African Health Sciences, 2024 - ajol.info
Background: Antiretroviral therapy is expected to produce sustained viral load reduction and
a rise in CD4 cell count, both of which are important clinical markers of immune recovery …
a rise in CD4 cell count, both of which are important clinical markers of immune recovery …
[PDF][PDF] Synthesis, optimization and analysis of hexavalent sulfoglycodendrimers as anti-HIV agents
CG Vierra - 2019 - scholars.csus.edu
A study into the green optimization of the synthesis of 4 unique and novel
sulfoglycodendrimers has been conducted. The ability of sulfoglycodendrimers to exhibit the …
sulfoglycodendrimers has been conducted. The ability of sulfoglycodendrimers to exhibit the …
[PDF][PDF] Journal of Pharmaceutical and Scientific Innovation
MH Kahissay, T Gedif, E Engedawork, TG Mariam - academia.edu
The initiation of ART is best based on CD4 cell count, a marker of immune status, rather than
on viral load, a marker of virologic replication. For patients with advanced symptoms …
on viral load, a marker of virologic replication. For patients with advanced symptoms …